Full Committee Hearing - Pharmacy Compounding: Implications of the 2012 Meningitis Outbreak
Date:
Thursday, November 15 2012, 9:45 AM
Place:
106 Dirksen Senate Office Building
Witnessesreturn to top
Panel I
- Dr. Beth Bell , Director, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA
- Dr. Peggy Hamburg , Commissioner, Food and Drug Administration, Washington, DC
- Dr. Lauren Smith , Interim Commissioner, Department of Public Health, Boston, MA
Panel II
- Barry Cadden , Owner and Director of Pharmacy, New England Compounding Center, Framingham, MA
Panel III
- Dr. Marion Kainer , Director, Healthcare Associated Infections & Antimicrobial Resistance Program, Tennessee Department of Health, Nashville, TN
- David G. Miller , Executive Vice President and CEO, International Academy of Compounding Pharmacy, Missouri City, TX
- Dr. Kasey K. Thompson , Vice President, Office of Policy, Planning and Communications, American Society of Health-System Pharmacists, Bethesda, MD
No comments:
Post a Comment